These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35901521)

  • 21. [Advances in the management of inflammatory bowel diseases].
    Reenaers C; Louis E
    Rev Med Liege; 2022 May; 77(5-6):323-329. PubMed ID: 35657190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are we using and monitoring thiopurines and biologics optimally?
    Irving PM
    Dig Dis; 2014; 32(4):410-8. PubMed ID: 24969289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.
    Schoepfer A; Vavricka SR; Brüngger B; Blozik E; Bähler C
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):350-357. PubMed ID: 31834046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of biologics in the treatment of patients with inflammatory bowel disease.
    Selinger CP; Carbery I; Al-Asiry J
    Br J Hosp Med (Lond); 2018 Dec; 79(12):686-693. PubMed ID: 30526103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of anti-TNF therapy (biologics) in the treatment of chronic inflammatory bowel disease in children].
    Kolacek S
    Acta Med Croatica; 2013 Apr; 67(2):89-92. PubMed ID: 24471292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive therapies for inflammatory bowel disease.
    Zenlea T; Peppercorn MA
    World J Gastroenterol; 2014 Mar; 20(12):3146-52. PubMed ID: 24696600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002.
    Bauer N; Kairey L; Schlee C; Uecker C; Öznur Ö; Langhorst J
    Scand J Gastroenterol; 2022 Oct; 57(10):1209-1215. PubMed ID: 35722930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologic therapies in inflammatory bowel disease.
    Cohen LB; Nanau RM; Delzor F; Neuman MG
    Transl Res; 2014 Jun; 163(6):533-56. PubMed ID: 24467968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management.
    Törüner M; Akpınar H; Akyüz F; Dağlı Ü; Över Hamzaoğlu H; Tezel A; Ünsal B; Yıldırım S; Çelik AF
    Turk J Gastroenterol; 2019 Nov; 30(Suppl 4):S913-S946. PubMed ID: 32207688
    [No Abstract]   [Full Text] [Related]  

  • 33. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
    Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
    Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inflammatory bowel disease].
    Vucelić B
    Reumatizam; 2013; 60(2):13-23. PubMed ID: 24979991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
    Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
    Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosimilars in inflammatory bowel disease.
    Talathi S; Baig KRKK
    J Dig Dis; 2020 Nov; 21(11):610-620. PubMed ID: 32920972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current and prospective biologics and small molecules in the treatment of inflammatory bowel diseases].
    Buc M
    Vnitr Lek; 2018; 64(3):280-289. PubMed ID: 29766731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders.
    Hirten RP; Iacucci M; Shah S; Ghosh S; Colombel JF
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1374-1384. PubMed ID: 29481970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy in inflammatory bowel disease - from traditional immunosuppressors towards the new paradigm of dual targeted therapy.
    Privitera G; Pugliese D; Onali S; Petito V; Scaldaferri F; Gasbarrini A; Danese S; Armuzzi A
    Autoimmun Rev; 2021 Jun; 20(6):102832. PubMed ID: 33866066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.